Unlocking the Potential of CTF18-Replication Factor C Complex: A Potential Drug Target and Biomarker

Target Name: CTF18-replication factor C complex

NCBI ID: P16333

Other Name(s): CTF18-replication factor C | CTF18-RFC

Unlocking the Potential of CTF18-Replication Factor C Complex: A Potential Drug Target and Biomarker

Introduction

The replication factor C complex (CTF18-replication factor C) plays a crucial role in the regulation of DNA replication in various organisms, including humans. It is a protein that contains several subunits, including C1, C2, C3, and C4, which work together to ensure the proper formation of double-stranded DNA during the replication process. The C complex is also known as the C-replication complex, and it is composed of various proteins that help to recruit and organize the necessary components for DNA replication.

Recent studies have identified CTF18-replication factor C as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and genetic disorders. In this article, we will delve into the research on CTF18-replication factor C and its potential as a drug target and biomarker.

The Importance of CTF18-replication factor C

CTF18-replication factor C is a critical protein that helps ensure the proper functioning of DNA replication. It plays a vital role in the regulation of the timing and order of the recruitment of the necessary components for DNA replication. C1, C2, C3, and C4, the subunits of the C complex, work together to recruit the necessary proteins and RNA factors for DNA replication, as well as to ensure the proper organization of the replication complex.

Research has shown that CTF18-replication factor C is involved in various cellular processes, including cell division, DNA replication, and transcription. It has been shown to play a role in the regulation of cell cycle progression, and it has been linked to the development and progression of various diseases.

As a Potential Drug Target

The potential use of CTF18-replication factor C as a drug target is based on its involvement in various cellular processes and its potential role in the development of various diseases. Several studies have shown that targeting CTF18-replication factor C may be an effective way to treat various diseases, including cancer, neurodegenerative diseases, and genetic disorders.

One of the main reasons for the potential use of CTF18-replication factor C as a drug target is its involvement in the regulation of DNA replication. Many diseases, including cancer, are caused by disruptions in DNA replication. By targeting CTF18-replication factor C , researchers may be able to reduce the risk of DNA replication errors and improve the effectiveness of cancer treatments.

Another potential use of CTF18-replication factor C as a drug target is its role in the development of neurodegenerative diseases. The C complex plays a crucial role in the regulation of DNA replication, and disruptions in this process have been linked to the development of neurodegenerative diseases. diseases. Targeting CTF18-replication factor C may be an effective way to treat neurodegenerative diseases and improve treatment outcomes.

In addition to its potential role in the regulation of DNA replication, CTF18-replication factor C has also been shown to play a role in the regulation of transcription. This suggests that it may be involved in the development of various diseases, including genetic disorders.

As a Potential Biomarker

The potential use of CTF18-replication factor C as a biomarker is based on its involvement in various cellular processes and its potential to be used as a diagnostic tool for various diseases. Several studies have shown that the levels of CTF18-replication factor C are involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

Research has also shown that changes in the levels of CTF18-replication factor C are involved in the development

Protein Name: CTF18-replication Factor C Complex

More Common Targets